Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Exogen Biotechnology

Exogen Biotechnology
2012 FOUNDED
PRIVATE STATUS
1-10 EMPLOYEES
Crowdfunding LATEST DEAL TYPE
$106K LATEST DEAL AMOUNT
3 INVESTORS
Description

Owner and operator of a company providing technologies to monitor DNA damage and to assess DNA repair capacities. The company provides services for individuals, organizations and research institutes to monitor damage to their DNA and to assess their DNA repair capacities for the purposes of personalized and preventive health care.

Ownership Status
Privately Held (backing)
Financing Status
Accelerator/Incubator Backed
Primary Industry
Biotechnology
Other Industries
Other Healthcare
Primary Office
  • QB3 East Bay Innovation Center
  • 820 Heinz Avenue
  • Berkeley, CA 94710
  • United States
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Exogen Biotechnology’s full profile, request a free trial.

Exogen Biotechnology Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Product Crowdfunding 26-Mar-2014 $106K Completed Startup
2. Grant 0000 Completed Startup
1. Accelerator/Incubator Completed Startup
To view this company’s complete deal history including valuation and funding, request access »

Exogen Biotechnology Investors (3)

Investor Name Investor Type Holding Investor Since Participating Rounds Board
Seat
Contact
Info
California Institute for Quantitative Biosciences Accelerator/Incubator 000 0000 000000 0
LAUNCH (UC Berkeley) Accelerator/Incubator Minority 000 0000 000000 0
Lawrence Berkeley National Laboratory Corporation 000 0000 000000 0

Exogen Biotechnology Executive Team (3)

Name Title Board
Seat
Contact
Info
Christian Keller Chief Executive Officer
Jonathan Tang Ph.D Co-Founder & Chief Technology Officer
Sylvain Costes Ph.D Co-Founder & CSO